Phenytoin: Pharmacogenetic polymorphism of 4′-hydroxylation
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 46 (3) , 341-347
- https://doi.org/10.1016/0163-7258(90)90022-t
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pharmacokinetics: Dose-Dependent ChangesThe Journal of Clinical Pharmacology, 1986
- The fate of orally administered [4-l4C]phenytoin in two healthy male volunteersCanadian Journal of Physiology and Pharmacology, 1983
- Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???Clinical Pharmacokinetics, 1983
- Phenytoin Michaelis-Menten Pharmacokinetics in Caucasian Paediatric PatientsClinical Pharmacokinetics, 1983
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patientThe Journal of Pediatrics, 1980
- Clinical Pharmacokinetics of PhenytoinClinical Pharmacokinetics, 1979
- A Study of the Pharmacokinetics of Phenytoin (Diphenylhydantoin) in Epileptic Patients, and the Development of a Nomogram for Making Dose IncrementsEpilepsia, 1975
- Decreased Capacity to Metabolize Diphenylhydantoin in a Patient with Hypersensitivity to WarfarinAustralian and New Zealand Journal of Medicine, 1975
- DIPHENYLHYDANTOIN HALF‐LIFE IN MAN AND ITS INHIBITION BY PHENYLBUTAZONE: THE ROLE OF GENETIC FACTORSActa Medica Scandinavica, 1973